11.7 Acceleration towards the Sustainable Development Goal targets for maternal health and child mortality

The Medicines Patent Pool recognises the importance of access to quality-assured and affordable medicines to reduce maternal and child mortality, and of the availability of optimal paediatric medicines in adapted formulations.

As a founding member of the Global Accelerator for Paediatric Formulations network, MPP welcomes the inclusion of two operational paragraphs addressing paediatric medicine formulations in the proposed resolution, marking a significant step forward in prioritising the needs of children.

MPP is also committed to enhancing access to essential medicines for maternal health, demonstrated by our recent memorandum of understanding and conditional licensing agreement with Ferring on access to heat-stable carbetocin for post-partum haemorrhage.

MPP remains committed to facilitating access to essential medicines in collaboration with WHO and Member States. Together, we can ensure that children and mothers receive the care they need, contributing to better health outcomes for future generations.